课题基金 / 基金详情

Role of viral infections in potassium channel-related cerebellar ataxia

Role of viral infections in potassium channel-related cerebellar ataxia
病毒感染在钾通道相关小脑共济失调中的作用
批准号:
10183352
负责人:
AKIKO IWASAKI
金额:
$54.02万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-18 至 2024-05-31
关键词:
Adaptor Signaling ProteinAddressAffectAftercareAgingAnimal ModelAnimalsAntiviral AgentsAtaxiaAtrophicAutophagocytosisBindingBiochemicalBiologicalBiological AssayBirthBrainCell DeathCell SurvivalCell membraneCell modelCell physiologyCellsCerebellar AtaxiaCerebellar degenerationCerebellumCessation of lifeCouplesDNA Sequence AlterationDataDefense MechanismsDependenceDevelopmentDevelopmental Delay DisordersDiseaseDistalElectroencephalographyEnzymesEtiologyExposure toFamilyFunctional disorderGenesGeneticGenitalGenitaliaGoalsHealthcare SystemsHumanIFNAR1 geneImmuneImpairmentIndividualInflammationInfluenza A virusInterferon Type IInterferon-alphaInterferon-betaInterferonsIon ChannelIonsKineticsLeadLifeLightLinkLocomotionLongevityMeasurementMolecularMolecular ProbesMucous MembraneMultivesicular BodyMusMutant Strains MiceMutationNeurobiologyNeurodegenerative DisordersNeuronsOnset of illnessPatch-Clamp TechniquesPathway interactionsPoint MutationPotassium ChannelPropertyProteinsPurkinje CellsRecombinant InterferonRespiratory SystemRoleSignal PathwaySignal TransductionSimplexvirusSite-Directed MutagenesisSliceSmall Interfering RNASpinocerebellar AtaxiasSymptomsTANK-binding kinase 1TestingToll-like receptorsVesicular stomatitis Indiana virusViralVirus Diseasesbasecellular pathologycytokinedisease-causing mutationearly onseteffective therapyexperimental studymiddle agemotor disordermotor symptommutantnovel therapeutic interventionpathogenprematureresponsestressortype I interferon receptorvoltage

项目摘要

项目成果

AKIKO IWASAKI的其他基金

相似基金

相关文献

中文摘要
翻译
小脑性共济失调是一种进行性神经退行性疾病,严重影响患者的日常生活
英文摘要
Cerebellar ataxia is a progressive neurodegenerative disease with major impact on the daily life of affected people, their families, and, on the health care system. There is no cure for cerebellar ataxia regardless of its origin. There is no effective treatment to slow the progression of symptoms that frequently lead to premature death. Ion channels have been implicated in the etiology of several form of cerebellar ataxia. For example, specific mutations in KCNC3, the gene encoding the Kv3.3 channel, such as the G592R point mutation, have been identified as the underlying genetic cause of late-onset spinocerebellar ataxia. Despite of these developments, there is no understanding of why late-onset cerebellar ataxias emerge in some but not all subjects with genetic mutations. There is also great variability in when during the lifespan of the affected subjects the symptoms emerge. Based on our unexpected preliminary observations, we hypothesize that disease onset in genetically vulnerable subjects is determined by host-pathogen interactions with particular emphasis on viral infections. Specifically, we assert that the synergistic activation of an intracellular signaling pathway that is targeted by both the mutant potassium channel and by viral defense mechanisms, impairs cellular function and results in the death of Purkinje cells. Our hypothesis and preliminary data challenge contemporary views on the etiology of cerebellar ataxia with implications for novel therapeutic strategies. We will test our hypothesis using cellular- and animal models with state-of-the-art neurobiological, molecular biological and immunobiological approaches.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of viral infections in potassium channel-related cerebellar ataxia
  • 批准号:
    10412975
  • 项目类别:
  • 资助金额:
    $54.02万
  • 财政年份:
    2019
  • 负责人:
    AKIKO IWASAKI
  • 依托单位:
Role of viral infections in potassium channel-related cerebellar ataxia
  • 批准号:
    10019610
  • 项目类别:
  • 资助金额:
    $54.02万
  • 财政年份:
    2019
  • 负责人:
    AKIKO IWASAKI
  • 依托单位:
Role of viral infections in potassium channel-related cerebellar ataxia
  • 批准号:
    10640848
  • 项目类别:
  • 资助金额:
    $54.02万
  • 财政年份:
    2019
  • 负责人:
    AKIKO IWASAKI
  • 依托单位:
B cell based protection against recurrent herpes
  • 批准号:
    9380483
  • 项目类别:
  • 资助金额:
    $41.88万
  • 财政年份:
    2017
  • 负责人:
    AKIKO IWASAKI
  • 依托单位:
海外基金